Related Experiment Video
Updated: May 22, 2026

Pentylenetetrazole-Induced Kindling Mouse Model
Published on: June 12, 2018
Nightmare-enacting behavior responding to zonisamide in early Parkinson's disease
Hiroshi Kataoka1, Satoshi Ueno
1Department of Neurology, Nara Medical University, Kashihara, Japan.
Abstract:
Recently, zonisamide (ZNS) has been approved as a new adjunctive therapy for motor complications of Parkinson's disease (PD). More recently, ZNS was reported to be effective for the management of impulse control behavior in PD, suggesting potential effects on non-motor PD symptoms. Dream enactment associated with aggressive, violent behavior can carry a serious risk of injury to patients, as well as to spouses or caretakers. This report describes a patient with PD who had vivid nightmares and dream-enacting behavior that resolved after treatment with ZNS. The present case raises the question whether ZNS might potentially be effective for the management of vivid nightmares or dream-enacting behavior.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Parkinson's Disease: Overview
Management of Insomnia
Neural Regulation
Parkinson Disease l: Introduction